164 related articles for article (PubMed ID: 34561608)
1. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study.
Lagerberg T; Fazel S; Sjölander A; Hellner C; Lichtenstein P; Chang Z
Neuropsychopharmacology; 2022 Mar; 47(4):817-823. PubMed ID: 34561608
[TBL] [Abstract][Full Text] [Related]
2. Predicting risk of suicidal behaviour after initiation of selective serotonin reuptake inhibitors in children, adolescents and young adults: protocol for development and validation of clinical prediction models.
Lagerberg T; Virtanen S; Kuja-Halkola R; Hellner C; Lichtenstein P; Fazel S; Chang Z
BMJ Open; 2023 Aug; 13(8):e072834. PubMed ID: 37612105
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation.
Lagerberg T; Matthews AA; Zhu N; Fazel S; Carrero JJ; Chang Z
Neuropsychopharmacology; 2023 Nov; 48(12):1760-1768. PubMed ID: 37507510
[TBL] [Abstract][Full Text] [Related]
4. Suicidality and self-injury with selective serotonin reuptake inhibitors in youth: Occurrence, predictors and timing.
Sørensen JØ; Rasmussen A; Roesbjerg T; Verhulst FC; Pagsberg AK
Acta Psychiatr Scand; 2022 Feb; 145(2):209-222. PubMed ID: 34374070
[TBL] [Abstract][Full Text] [Related]
5. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
6. A naturalistic study of suicidal adolescents treated with an SSRI: suicidal ideation and behavior during 3-month post-hospitalization period.
Ghaziuddin N; Merchant C; Dopp R; King C
Asian J Psychiatr; 2014 Oct; 11():13-9. PubMed ID: 25453691
[TBL] [Abstract][Full Text] [Related]
7. An association between initiation of selective serotonin reuptake inhibitors and suicide - a nationwide register-based case-crossover study.
Björkenstam C; Möller J; Ringbäck G; Salmi P; Hallqvist J; Ljung R
PLoS One; 2013; 8(9):e73973. PubMed ID: 24040131
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases.
Dubrall D; Fekete S; Leitzen S; Paschke LM; Romanos M; Schmid M; Gerlach M; Sachs B
BMC Pharmacol Toxicol; 2023 Mar; 24(1):22. PubMed ID: 37004083
[TBL] [Abstract][Full Text] [Related]
9. Associations between selective serotonin reuptake inhibitors and violent crime in adolescents, young, and older adults - a Swedish register-based study.
Lagerberg T; Fazel S; Molero Y; Franko MA; Chen Q; Hellner C; Lichtenstein P; Chang Z
Eur Neuropsychopharmacol; 2020 Jul; 36():1-9. PubMed ID: 32475742
[TBL] [Abstract][Full Text] [Related]
10. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
KoKoAung E; Cavenett S; McArthur A; Aromataris E
JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
[TBL] [Abstract][Full Text] [Related]
11. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
[TBL] [Abstract][Full Text] [Related]
12. SSRIs and risk of suicide attempts in young people - A Danish observational register-based historical cohort study, using propensity score.
Christiansen E; Agerbo E; Bilenberg N; Stenager E
Nord J Psychiatry; 2016; 70(3):167-75. PubMed ID: 26251067
[TBL] [Abstract][Full Text] [Related]
13. Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior.
Lagerberg T; Sjölander A; Gibbons RD; Quinn PD; D'Onofrio BM; Hellner C; Lichtenstein P; Fazel S; Chang Z
Front Psychiatry; 2022; 13():1012650. PubMed ID: 36440412
[TBL] [Abstract][Full Text] [Related]
14. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
[TBL] [Abstract][Full Text] [Related]
16. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants and suicide attempts in children.
Cooper WO; Callahan ST; Shintani A; Fuchs DC; Shelton RC; Dudley JA; Graves AJ; Ray WA
Pediatrics; 2014 Feb; 133(2):204-10. PubMed ID: 24394688
[TBL] [Abstract][Full Text] [Related]
18. SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.
Grunebaum MF; Keilp JG; Ellis SP; Sudol K; Bauer N; Burke AK; Oquendo MA; Mann JJ
J Clin Psychiatry; 2013 Sep; 74(9):872-9. PubMed ID: 24107760
[TBL] [Abstract][Full Text] [Related]
19. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
Czaja AS; Valuck RJ; Anderson HD
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
[TBL] [Abstract][Full Text] [Related]
20. Transgenerational concordance in parent-to-child transmission of suicidal behaviour: a retrospective, nationwide, register-based cohort study of 4 419 642 individuals in Denmark.
Ranning A; Madsen T; Hawton K; Nordentoft M; Erlangsen A
Lancet Psychiatry; 2022 May; 9(5):363-374. PubMed ID: 35354063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
